Matches in SemOpenAlex for { <https://semopenalex.org/work/W3091843313> ?p ?o ?g. }
- W3091843313 endingPage "188446" @default.
- W3091843313 startingPage "188446" @default.
- W3091843313 abstract "Angiogenesis is required in cancer, including gynecological cancers, for the growth of primary tumors and secondary metastases. Development of anti-angiogenesis therapy in gynecological cancers and improvement of its efficacy have been a major focus of fundamental and clinical research. However, survival benefits of current anti-angiogenic agents, such as bevacizumab, in patients with gynecological cancer, are modest. Therefore, a better understanding of angiogenesis and the tumor microenvironment in gynecological cancers is urgently needed to develop more effective anti-angiogenic therapies, either or not in combination with other therapeutic approaches. We describe the molecular aspects of (tumor) blood vessel formation and the tumor microenvironment and provide an extensive clinical overview of current anti-angiogenic therapies for gynecological cancers. We discuss the different phenotypes of angiogenic endothelial cells as potential therapeutic targets, strategies aimed at intervention in their metabolism, and approaches targeting their (inflammatory) tumor microenvironment." @default.
- W3091843313 created "2020-10-15" @default.
- W3091843313 creator A5004064474 @default.
- W3091843313 creator A5011288026 @default.
- W3091843313 creator A5017732186 @default.
- W3091843313 creator A5023783658 @default.
- W3091843313 creator A5035739363 @default.
- W3091843313 creator A5048381033 @default.
- W3091843313 creator A5059883802 @default.
- W3091843313 creator A5066063239 @default.
- W3091843313 creator A5085918635 @default.
- W3091843313 creator A5088114897 @default.
- W3091843313 creator A5089016518 @default.
- W3091843313 creator A5089127427 @default.
- W3091843313 creator A5091329513 @default.
- W3091843313 date "2021-01-01" @default.
- W3091843313 modified "2023-10-16" @default.
- W3091843313 title "Angiogenesis in gynecological cancers and the options for anti-angiogenesis therapy" @default.
- W3091843313 cites W103541336 @default.
- W3091843313 cites W1487922930 @default.
- W3091843313 cites W1519147104 @default.
- W3091843313 cites W1522554466 @default.
- W3091843313 cites W1555664180 @default.
- W3091843313 cites W1559595253 @default.
- W3091843313 cites W1574424832 @default.
- W3091843313 cites W1580190537 @default.
- W3091843313 cites W1589561469 @default.
- W3091843313 cites W1656339735 @default.
- W3091843313 cites W1721827275 @default.
- W3091843313 cites W184854032 @default.
- W3091843313 cites W1965154864 @default.
- W3091843313 cites W1966726954 @default.
- W3091843313 cites W1970429237 @default.
- W3091843313 cites W1970614272 @default.
- W3091843313 cites W1971162717 @default.
- W3091843313 cites W1972383287 @default.
- W3091843313 cites W1973639059 @default.
- W3091843313 cites W1974210097 @default.
- W3091843313 cites W1975959171 @default.
- W3091843313 cites W1976681763 @default.
- W3091843313 cites W1977881408 @default.
- W3091843313 cites W1978139448 @default.
- W3091843313 cites W1982126453 @default.
- W3091843313 cites W1983244945 @default.
- W3091843313 cites W1983505913 @default.
- W3091843313 cites W1987846826 @default.
- W3091843313 cites W1989311738 @default.
- W3091843313 cites W1990253071 @default.
- W3091843313 cites W1990486425 @default.
- W3091843313 cites W1992112921 @default.
- W3091843313 cites W1994678099 @default.
- W3091843313 cites W1995160678 @default.
- W3091843313 cites W1996961250 @default.
- W3091843313 cites W1997287998 @default.
- W3091843313 cites W2000909793 @default.
- W3091843313 cites W2001482579 @default.
- W3091843313 cites W2002621910 @default.
- W3091843313 cites W2002710053 @default.
- W3091843313 cites W2003025783 @default.
- W3091843313 cites W2003225436 @default.
- W3091843313 cites W2003278910 @default.
- W3091843313 cites W2003305754 @default.
- W3091843313 cites W2004578920 @default.
- W3091843313 cites W2005577087 @default.
- W3091843313 cites W2006202974 @default.
- W3091843313 cites W2006618501 @default.
- W3091843313 cites W2007687296 @default.
- W3091843313 cites W2008080411 @default.
- W3091843313 cites W2008774890 @default.
- W3091843313 cites W2010596234 @default.
- W3091843313 cites W2011408698 @default.
- W3091843313 cites W2011810742 @default.
- W3091843313 cites W2012483332 @default.
- W3091843313 cites W2013288089 @default.
- W3091843313 cites W2013631219 @default.
- W3091843313 cites W2017018900 @default.
- W3091843313 cites W2017311183 @default.
- W3091843313 cites W2017322644 @default.
- W3091843313 cites W2018009062 @default.
- W3091843313 cites W2018860781 @default.
- W3091843313 cites W2018918678 @default.
- W3091843313 cites W2019065738 @default.
- W3091843313 cites W2021173171 @default.
- W3091843313 cites W2023592701 @default.
- W3091843313 cites W2024264494 @default.
- W3091843313 cites W2024290930 @default.
- W3091843313 cites W2025149885 @default.
- W3091843313 cites W2026033409 @default.
- W3091843313 cites W2026530967 @default.
- W3091843313 cites W2026831351 @default.
- W3091843313 cites W2028155508 @default.
- W3091843313 cites W2029347126 @default.
- W3091843313 cites W2029436635 @default.
- W3091843313 cites W2029712941 @default.
- W3091843313 cites W2031536699 @default.
- W3091843313 cites W2032126939 @default.
- W3091843313 cites W2032841298 @default.
- W3091843313 cites W2034269086 @default.